Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride shows promise for female hair loss, but more research needed.

Sex hormones affect brain injury differently in males and females.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.